Investor FAQs

Show All
Where is Collegium headquartered?
100 Technology Center Drive, Suite 300, Stoughton, MA 02072
Where is Collegium incorporated?
Collegium is incorporated in Virginia.
When was Collegium founded?
Collegium was founded in 2002.
Which stock exchange are Collegium shares traded on and what is the company’s ticker?
Collegium’s shares are traded on the Nasdaq Global Market under the symbol COLL.
When did Collegium go public?
Collegium’s initial public offering (IPO) occurred on May 7, 2015.
When does Collegium’s fiscal year end?
Collegium’s fiscal year ends on December 31.
Who is Collegium’s independent registered public accounting firm?
Deloitte & Touche LLP
Who is Collegium’s legal counsel?
Troutman Pepper
What is Collegium’s CUSIP number?
The CUSIP number for COLL is 19459J104.
How can I purchase Collegium shares?
Shares of Collegium’s stock can be purchased by contacting a securities broker of your choice.
Does Collegium pay dividends and have a dividend reinvestment program?
Collegium does not currently pay dividends or offer a stock reinvestment plan.
Who is Collegium’s transfer agent?
Computershare Trust Company, N.A.
P.O. BOX 505000
Louisville, KY 40233-5000
TEL: (877) 373-6374
Whom do I contact with questions about my stock (transfer stock, change the address on my shareholder account, or replace a lost stock certificate)?
For questions about your stock please contact our transfer agent, Computershare Trust Company, N.A.
How can I view documents Collegium has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
Quarterly & Annual reports and other investor materials are available in the “Investors” section of Collegium’s corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at www.sec.gov.
How can I sign up to receive Collegium press releases and other company information?
Please click here to be directed to the email alerts page.
Whom should I contact if I am a member of the media?
Whom should I contact if I have additional questions?
For investor inquiries, please send an email to Investors@collegiumpharma.com